drugset / Trial / NCT02072018
Peyronie's Disease Treatment Protocol
RandomizedCrossoverTriple-blindTreatment
Summary
Treatment of Peyronie's disease remains difficult. The purpose of this study is to test the safety and efficacy of a new compound to treat this disease.
Timeline
- Start
- 2013-06
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | H-100 | Small molecule | — | — |